Scholarlink

Background <p>Alzheimer’s disease (AD) is characterized by a gradual buildup of beta amyloid (Aβ) and tau proteins, which disrupt the balance between neuronal excitation and inhibition (E-I), leading to dysfunction in neural network activity. In this study, we examined the aperiodic exponent as a putative marker of neuronal E-I balance in cognitively unimpaired amyloid negative and amyloid positive individuals, as well as in patients with prodromal AD, and assessed its association with tau pathology.</p> Methods <p>High-density electroencephalography (EEG) data was recorded in response to visual gamma stimulation, and 100-minute tau PET scans were obtained from 64 individuals, 33 across the AD continuum (16 individuals in the biomarker-proven prodromal AD stage and 17 cognitively unimpaired amyloid positive) and 31 cognitively unimpaired amyloid negative individuals.</p> Results <p>Our results show a significant between-group difference in the aperiodic exponent and reveal distinct patterns of E-I balance across different brain regions. Furthermore, we demonstrate that the aperiodic exponent can distinguish prodromal AD individuals from cognitively unimpaired peers and is negatively associated with tau PET load in brain regions typically affected in the early stages of AD.</p> Conclusions <p>Our findings suggest that the E-I imbalance may already emerge during the asymptomatic and prodromal AD stages and can vary across brain regions. While further validation is needed, our results support the potential of EEG-based methods as a noninvasive tool for capturing early neural changes due to AD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Early aperiodic EEG changes in preclinical and prodromal Alzheimer’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月8日

查看全文
  • Tjaša Mlinarič,
  • Laure Spruyt,
  • Elvira Khachatryan,
  • Benjamin Wittevrongel,
  • Mariska Reinartz,
  • Koen Van Laere,
  • Patrick Dupont,
  • Rik Vandenberghe,
  • Marc M. Van Hulle

摘要

Background

Alzheimer’s disease (AD) is characterized by a gradual buildup of beta amyloid (Aβ) and tau proteins, which disrupt the balance between neuronal excitation and inhibition (E-I), leading to dysfunction in neural network activity. In this study, we examined the aperiodic exponent as a putative marker of neuronal E-I balance in cognitively unimpaired amyloid negative and amyloid positive individuals, as well as in patients with prodromal AD, and assessed its association with tau pathology.

Methods

High-density electroencephalography (EEG) data was recorded in response to visual gamma stimulation, and 100-minute tau PET scans were obtained from 64 individuals, 33 across the AD continuum (16 individuals in the biomarker-proven prodromal AD stage and 17 cognitively unimpaired amyloid positive) and 31 cognitively unimpaired amyloid negative individuals.

Results

Our results show a significant between-group difference in the aperiodic exponent and reveal distinct patterns of E-I balance across different brain regions. Furthermore, we demonstrate that the aperiodic exponent can distinguish prodromal AD individuals from cognitively unimpaired peers and is negatively associated with tau PET load in brain regions typically affected in the early stages of AD.

Conclusions

Our findings suggest that the E-I imbalance may already emerge during the asymptomatic and prodromal AD stages and can vary across brain regions. While further validation is needed, our results support the potential of EEG-based methods as a noninvasive tool for capturing early neural changes due to AD.